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Abstract
Natural HIV-1 protease (PR) is homodimeric. Some researchers believe that interactions between HIV-1 Gag-Pol molecules
trigger the activation of embedded PR (which mediates Gag and Gag-Pol cleavage), and that Gag-Pol assembly domains
outside of PR may contribute to PR activation by influencing PR dimer interaction in a Gag-Pol context. To determine if the
enhancement of PR dimer interaction facilitates PR activation, we placed single or tandem repeat leucine zippers (LZ) at the
PR C-terminus, and looked for a correlation between enhanced Gag processing efficiency and increased Gag-PR-LZ
multimerization capacity. We found significant reductions in virus-like particles (VLPs) produced by HIV-1 mutants, with LZ
fused to the end of PR as a result of enhanced Gag cleavage efficiency. Since VLP production can be restored to wt levels
following PR activity inhibition, this assembly defect is considered PR activity-dependent. We also found a correlation
between the LZ enhancement effect on Gag cleavage and enhanced Gag-PR multimerization. The results suggest that PR
dimer interactions facilitated by forced Gag-PR multimerization lead to premature Gag cleavage, likely a result of premature
PR activation. Our conclusion is that placement of a heterologous dimerization domain downstream of PR enhances PR-
mediated Gag cleavage efficiency, implying that structural conformation, rather than the primary sequence outside of PR, is
a major determinant of HIV-1 PR activation.
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Introduction
Human immunodeficiency virus type 1 (HIV-1) gag encodes a
polypeptide Pr55
gag that can self-assemble into virus-like particles
(VLPs) [1]. During or soon after virus release from cells, Pr55
gag is
cleaved by viral protease (PR) into four major products: matrix
(MA, p17), capsid (CA, p24), nucleocapsid (NC, p7), and p6
domains [1]. PR is encoded by pol, which is initially translated as a
Pr160
gag-pol polyprotein by a ribosomal frameshift event that occurs
at a frequency of 5%, resulting in the expression of Pr160
gag-pol to
Pr55
gag at a ratio of approximately 1:20 [2]. Pr160
gag-pol is
incorporated into virions via interactions with assembling Pr55
gag
[3,4,5,6,7,8]. Pr160
gag-pol cleavage by PR yields reverse transcrip-
tase (RT) and integrase (IN) in addition to Gag products. The PR-
mediated proteolytic cleavage of Pr55
gag and Pr160
gag-pol, known as
virus maturation, is essential for the acquisition of viral infectivity
[9,10,11,12,13].
How PR is activated to mediate virus maturation is not
completely clear. One proposal is that interaction among Pr160
gag-
pol molecules triggers the activation of embedded PR, which in
homodimeric form mediates Gag and Gag-Pol cleavage following
PR autocleavage from Pr160
gag-pol. Maintenance of the Pr55
gag/
Pr160
gag-pol expression ratio is critical to virus assembly; the
artificial overexpression of Pr160
gag-pol or PR drastically reduces
virion production as a result of enhanced Gag processing by
overexpressed PR activity [14,15,16,17,18,19,20]. Equally impor-
tant is the Pr160
gag-pol sequence and structure, since sequence
mutations upstream or downstream of PR often result in defective
virus maturation or Gag cleavage [4,21,22,23,24]. Impaired Gag
cleavage is assumed as being due, at least in part, to impaired PR
activation, which is likely secondary to inadequate PR dimer
interaction. Since natural RT is heterodimeric [25,26], there is
speculation that RT in the Gag-Pol context facilitates Pr160
gag-pol-
Pr160
gag-pol interaction via RT-RT interaction, which in turn
influences PR activation. Consistent with this scenario, RT
deletion mutations can lead to severely impaired PR-mediated
Gag processing [23]. In addition, efavirenz (EFV), a non-
nucleoside reverse transcriptase inhibitor that enhances RT
dimerization in vitro [27,28], reduces virus production as a result
of greatly enhanced Gag and Gag-Pol cleavage [29,30].
Furthermore, a single amino acid substitution in RT (W402A)
leads to significantly reduced virus production due to markedly
enhanced PR-mediated Gag cleavage [31]. Combined, these data
suggest that the RT domain plays an important role in PR
activation by influencing PR dimer interaction.
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mutation significantly impacts PR dimer interaction, resulting in
premature or impaired PR activation. Accordingly, structural
conformations rather than specific sequences may be major
determinants of the PR activation process. A protein sequence
unrelated to HIV-1 but possessing dimerization capacity may
therefore promote PR activation by facilitating PR dimer
interaction when fused to the end of PR. To test this possibility,
we removed the RT and IN sequences and placed a leucine zipper
(LZ)-coding sequence at the C-terminus of PR. Results indicate
that LZ placement significantly reduced virion release due to
enhanced Gag cleavage, similar to observations for RT W402A
mutations. These results support the hypothesis that the placement
of heterologous protein dimerization sequences downstream of PR
can significantly enhance Gag processing efficiency by promoting
PR activation.
Results
Placement of leucine zipper motifs at the C-terminus of
PR results in significantly reduced virion production
To determine whether forced PR dimer interactions affect virus
assembly and processing, we fused a LZ protein dimerization
domain either singly or in tandem repeat to the C-terminus of an
HIV-1 Gag-Pol truncated construct (Gag/PR), which is virus-
assembly competent but processing-defective [23]. The resulting
constructs were designated PRWz and PRWWz (Fig. 1). We used
PRKz and PRKKz constructs containing the dimerization-
defective LZ mutant version (Kz) as controls. Kz fusion to PRWz
at the wt LZ C- and N-termini yielded constructs PRWKz and
PRKWz, respectively. Each mutant was transiently expressed in
293T cells. Virus particle assembly and processing were analyzed
by Western immunoblotting. The results shown in Figure 2A
indicate that Gag/PR transfectants produced substantial quanti-
ties of VLPs at levels that were near wild-type. Unprocessed Gag
(the Gag precursor Pr55) and incompletely processed Gag (the
intermediate p41gag) represent two major Gag products com-
pared to wt in our supernatant and cell samples (Fig. 2A, lanes 1
vs. 2). This is consistent with a report stating that a deletion in a
downstream pol sequence significantly impairs PR-mediated virus
maturation [23].
PRWz and PRWWz transfectants expressed readily detectable
Gag, but produced barely detectable virus-associated Gag,
suggesting a severe defect in virus assembly or release (Fig. 2A,
lanes 3 and 4). In contrast, cells transfected with PRKz or PRKKz
released readily detectable (though incompletely processed) Gag
(lanes 5 and 6), similar to the Gag/PR scenario. VLP levels
produced by PRWKz and PRKWz (lanes 7 and 8) were in-
between those produced by PRWz and PRKz. Since enhanced or
premature Gag cleavage by PR can lead to significantly reduced
virus release, and since the wt LZ fusion-containing constructs
exhibited higher ratios of cellular p24
gag to Pr55
gag compared to
those found in Gag/PR cell lysates (Fig. 2A, lanes 3–4 vs. lane 2),
we suggest that the LZ-associated virus production defect was
largely due to enhanced Pr55
gag cleavage efficiency.
Since cell samples were collected between 48 and 72 h post-
transfection, it is possible that Gag processing reached a level of
stability that prevented us from detecting any differences in
efficiency between the wt form and mutants. To test this
possibility, and to confirm the effect of LZ domain placement on
Gag processing efficiency, we collected samples at 24 and 48 h
following the transient expression of wt and mutants. We observed
that both PRWz and PRWWz showed significantly higher cellular
p24
gag/Pr55
gag ratios compared to those of wt or Gag/PR (Fig. 2B).
Although PRWKz and PRKWz showed cellular Gag processing
profiles similar to those of PRKz and PRKKz at 48 h, they
displayed higher p24
gag/Pr55
gag ratios compared to Gag/PR at
24 h post-transfection (Fig. 2B upper panel, lanes 15–16 vs. lane
10). This suggests that LZ domain placement significantly
enhanced Gag processing efficiency. The virus-associated Gag
precursor that we detected may reflect, at least in part, the release
of assembled Gag molecules that escaped PR-mediated cleavage
(Fig. 2B, lanes 7–8).
To determine whether LZ placement affected virion production
by wt or assembly-competent mutants in trans, we coexpressed
PRWz or PRWWz with the wt or the HIV-1 protease-defective
mutant D25, and observed that virus-associated Gag was markedly
reduced when D25 was cotransfected with either PRWz or
PRWWz at a 1:1 ratio (Fig. 2C). Similar results were observed
when the PRWz or PRWWz was coexpressed with a wt HIV-1
expression vector (data not shown). Combined, these results
suggest that (a) PRWz and PRWWz both provided functional PR,
and (b) the LZ-triggered virion assembly defect was primarily due
to a higher Gag cleavage efficiency. The PRWWz transfectant
frequently expressed a lower Gag level compared to other
constructs (Fig. 2B, lane 12), likely the result of increased
proteolytic degradation of Gag mediated by the PR.
The PRWWz virus assembly defect is PR activity-
dependent
To determine whether the PRWz or PRWWz assembly defect is
directly associated with viral PR activity, we treated PRWz and
PRWWz transfectants with Saquinavier, an HIV-1 PR inhibitor
(designated as PI). As expected, virus-associated PRWWz Gag
(Pr55
gag and p41
gag) that was previously undetectable (or barely
detectable) became readily detectable when PI concentrations
were gradually increased (Fig. 3A). We noticed that wt cellular
p24
gag was still easily detected, even though PRWWz p24
gag was
undetectable under the same treatment conditions (Fig. 3A, lanes 3
vs. 7). This suggests that PRWWz is more susceptible to a protease
inhibitor than wt, despite having higher Gag cleavage efficiency.
Since we centrifuged the culture supernatant through 20%
sucrose cushions, we assumed that the recovered Gag would be
present in pelleted particles. To confirm that the recovered Gag
was from VLPs, we observed supernatant samples (Fig. 3B) with a
transmission electron microscope, and found spherical wt and
mutant Gag particles with electron-dense cores in PI-treated
transfectant samples (Figs. 3D and 3F). However, mature virions
with cone-shaped cores were only detected in non-PI-treated wt
transfectant samples (Fig. 3C). Some vesicles lacking cores were
noted, but virion-size particles containing electron-dense cores
were not detected in mock-transfected samples, or barely detected
in PRWWz transfectant supernatant that had not been treated
with PI (Figs. 3E and 3G). These data support the hypothesis that
the LZ-incurred assembly defect is PR activity-dependent.
LZ enhancement of Gag cleavage is correlated with
increased Gag-PR-LZ multimerization capacity
We looked for correlations between enhanced PR-mediated
Pr55
gag cleavage efficiency and increased Gag-PR-LZ multi-
merization capacity. Believing that the potent Gag assembly
domain might determine chimera multimerization status, we
predicted that the contribution of LZ to enhanced chimera
multimerization would be barely (if at all) detectable. We therefore
assessed chimera multimerization capacity in a Gag assembly-
defective context. After constructing an assembly-defective mutant
(designated MoGag) and confirming that the mutation significant-
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into MoGag. To block the effect of PR activity on Gag-PR-LZ
chimera assembly assays, all chimeras were introduced into a PR-
inactivated HIV-1 Pr160
gag-pol-expression plasmid GPfs [4], with
gag and pol in the same reading frame (Fig. 4A). Results from
repeated independent experiments indicate that chimeras with
predicted molecular weights were detected in both supernatants
and cell lysates following transient expression in 293T cells,
suggesting that all chimeras were capable of assembly and release
to some extent. However, we noted that MoGagfsWz transfectants
produced more chimeric VLPs than MoGagfsD or MoGagfsKz
(Figs. 4C and 4D). To confirm that MoGag was multimerization-
defective and that LZ did enhance assembly-defective Gag
multimerization, we subjected wt Gag and each mutant to velocity
sedimentation analyses. A non-myristylated (myr-) Gag mutant
[32] known to be severely defective in both membrane binding
and multimerization served as a negative control. Our data
indicate that most of the wt Gag was recovered at fractions 3 to 5;
in contrast, most myr- Gag and substantial amounts of MoGag
were recovered at fractions 1 and 2. Portions of MoGagfsD and
MoGagfsKz were detected at lower sucrose density fractions,
whereas MoGagfsWz was almost completely recovered at higher
sucrose density fractions (Fig. 4E). Unlike MoGagfsWz, which
mostly sedimented at fractions 4 and 5, considerable amounts of
MoGagfsWKz and MoGagfsKWz were also recovered at fraction
3, and low but detectable amounts were observed in fraction 2.
This sedimentation pattern was similar to that of MoGagfsKz
(Fig. 4E, three bottom panels). Also similar to MoGagfsKz, both
MoGagfsWKz and MoGagfsKWz were incapable of efficiently
assembling into chimeric VLPs (data not shown). We observed this
result in repeated independent experiments. This finding suggests
that when fused to the PR C-terminus, a LZ tandem repeat
containing a wt and mutant LZ (WKz or KWz) does not enhance
Gag-PR multimerization as effectively as a wt LZ tandem repeat
(Wz). This may partly explain why PRWKz and PRKWz showed
relatively lower Gag cleavage efficiency compared to PRWWz
(Fig. 2).
Compared to MoGag, which had significant amounts of Gag
detected at lower sucrose density fractions (1 and 2), MoGagfsD
molecules were mostly sedimented at fractions 3 to 5, a difference
that may be explained in part by p6
pol-PR contributing to
MoGagfsD multimerization via PR dimer interaction. Although
GagfsD presented an efficient multimerization profile, it produced
VLPs at a relatively lower level compared to WtGag (Figs. 4C and
4D). This may have been due to its lack of p6
gag, which is required
for efficient virus budding [33,34].
Our next question was whether LZ enhanced the cleavage
efficiency of the assembly-defective mutant MoGag. MoGag with
an LZ fusion was expressed in a Gag/PR context, thus expressing
both Pr55
gag and PR containing Gag-Pol or Gag-PR(-LZ) fusions
(Fig. 5A). As expected, the insertion of LZ into MoGag/PR at the
PR C-terminus resulted in significantly enhanced Gag cleavage
efficiency (Fig. 5C, lanes 11 vs. 15), suggesting that the LZ
enhancement of Gag-PR multimerization is correlated with
increased PR-mediated Gag cleavage efficiency. Inefficient Gag
cleavage, likely due to either impaired PR activation as a result of
Pol truncation or to inhibited PR activity due to a protease
inhibitor, resulted in improved MoGag VLP assembly (Fig. 5C,
Figure 1. Schematic representations of HIV-1 Gag and Gag-PR-leucine zipper expression constructs. WT and D25 both expressed
Pr55
gag and Pr160
gag-pol. Indicated are the HIV Gag protein domains MA (matrix), CA (capsid), NC (nucleocapsid), p6, pol-encoded p6
pol, PR, and RT.
The ‘‘X’’ in D25 denotes a PR-inactivated mutation. Gag/PR contains a stop codon insertion at the PR-RT junction, with a codon sequence of 59-TTT
CCC ATT AGC CCT TAG-39 (RT codons underlined). Striped (Wz) and dotted (Kz) boxes denote wild-type (wt) and mutant (Kz) leucine zipper (LZ)
domains, respectively, with each placed individually or in tandem repeat at the end of Gag/PR. Note that the chimeric constructs contain a linker of
four Gly residues between the end of PR and beginning of LZ, and a separate linker of three Gly residues between the linked LZ domains.
doi:10.1371/journal.pone.0032845.g001
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defect is PR activity-dependent, at least in part. The MoPRWWz
had significantly higher cellular p24
gag/Pr55
gag ratios compared to
MoGag/PR, but slightly lower compared to PRWWz (Figs. 5B
and 5C), suggesting that the multimerization-defective Gag
mutation reduced the LZ-mediated enhancement of Gag cleavage.
It also supports the proposal that the Gag assembly domain plays a
role in PR activation.
Although myristylation is not required for Gag-Pol viral
incorporation [7,35], it is essential for Gag multimerization and
virus assembly [11,36]. To determine if a myristylation signal is
necessary for the LZ enhancement effect on Gag cleavage, we
introduced myr- into wt, Gag/PR, PRWWz, and PRKKz, and
measured the Gag processing efficiency of each mutant. Our
results indicate an efficient Gag processing profile for myr-
PRWWz, similar to that of its myristylation-positive counterpart,
Figure 2. Effects of leucine zipper insertion on virus assembly and processing. (A–B) 293T cells were transfected with designated
constructs Panel A: At 48–72 h, cells and culture supernatant were collected. Panel B: At 4 h post-transfection, equal amounts of cells were placed on
two dish plates. Cells and culture supernatants were collected at 24 and 48 h post-transfection and subjected to Western immunoblotting. HIV-1 Gag
proteins were probed with an anti-p24CA monoclonal antibody. Pr55
gag, p41
gag, and p24
gag positions are indicated. Cellular Pr55
gag and p24
gag levels
were quantified by scanning Pr55
gag and p24
gag band densities from immunoblots. Ratios of p24
gag to p55
gag were determined for the wt and each
mutant (panel A, bottom), or normalized to those of wt in parallel experiments (panel B). Values were derived from three independent experiments.
Bars indicate standard deviation. **, p,0.01. (C) 293T cells were transfected with 10 mg of D25, PRWz, or PRWWz plasmid alone (lanes 1–3); 10 mg D25
plus 10 mg PRWz (lane 4) or PRWWz (lane 5); or 10 mg D25 plus 2 mg PRWz (lane 6) or PRWWz (lane 7). For each transfection, plasmid DNA amounts
were maintained at 20 mg by adding pBlueScript SK. At 48–72 h post-transfection, culture supernatant and cells were collected and subjected to
Western immunoblotting.
doi:10.1371/journal.pone.0032845.g002
Figure 3. The PRWWz assembly defect is HIV-1 protease activity-dependent. (A) 293T cells were transfected with wt or mutant plasmids. At
4 h post-transfection, cells were replated on four dish plates and either left untreated (lanes 1 and 5) or treated with the HIV-1 protease inhibitor (PI)
Saquinavier at concentrations of 0.01 (lanes 2 and 6), 0.1 (lanes 3 and 7), or 1.0 mM (lanes 4 and 8). At 48–72 h post-transfection, cells and culture
supernatant were collected, prepared, and subjected to Western immunoblot analysis. (B–G) Transmission electron microscopy images of
concentrated culture supernatant from 293T cells expressing the wt or PRWWz. Culture supernatants from PI-treated or untreated transfectants were
collected, filtered, and pelleted through 20% sucrose cushions. Virus-containing pellets resuspended in PBS buffer were subjected to Western
immunoblotting (panel B) and transmission electron microscopy. The high-power view (660,000 magnification) in the inset shows cone-shaped cores
(arrowheads) that are characteristic of mature wt virus particles (Panel C). Bars, 200 nm.
doi:10.1371/journal.pone.0032845.g003
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PLoS ONE | www.plosone.org 6 March 2012 | Volume 7 | Issue 3 | e32845PRWWz (Fig. 6). Since myristylation is essential to Gag membrane
binding and virus assembly, we failed to detect virus-associated
Gag products in any of the myr- supernatant samples (data not
shown). This suggests that the LZ insertion made a significant
contribution to enhanced Gag cleavage, regardless of the presence
or absence of a myristylation signal.
Discussion
Despite a lack of direct evidence, it is generally accepted that
Gag-Pol molecule dimerization or multimerization triggers HIV-1
PR activation, which mediates Gag and Gag-Pol cleavage. Here
we demonstrated that the insertion of LZ at the C-terminus of PR
triggers markedly enhanced PR-mediated Gag cleavage efficiency,
which is associated with increased Gag-PR multimerization
capacity. This suggests that an HIV-1-unrelated protein sequence
capable of self-association can enhance Gag cleavage efficiency
when fused to the PR C-terminus. It also provides evidence in
support of the assumption that Gag-Pol/Gag-Pol interaction
triggers PR activation.
In an assembly-competent Gag/PR context, the wt LZ insertion
resulted in markedly reduced, PR activity-dependent virus
production (Fig. 2). Cellular Pr55
gag was barely detected in
PRWWz at 12 and 24 h post-transfection, while most Pr55
gag
remained unprocessed in wt transfectants 12 h post-transfection
(data not shown). Combined, these results suggest that LZ-
enhanced Gag cleavage is associated with premature Gag
processing due to premature PR activation. We suggest that when
fused at the PR C-terminus, the LZ domain facilitates PR-PR
interaction via enhanced interactions among MA-CA-NC-PR-LZ
chimeras. Gag is subsequently cleaved by PR in trans, either by PR
embedded in the chimera, or by a mature and fully processed PR
dimer.
Several researchers have suggested that the PR-mediated initial
cleavage occurs via an intramolecular mechanism
[37,38,39,40,41]. Although we did not search for the presence of
a PR dimer, PR was theoretically capable of being released from
the chimera as a fully processed dimer, since the cleavage site at
the PR/LZ junction remained intact. Compared to the wt LZ
fusion, the placement of a mutant LZ (Kz) at either the N- or C-
terminus of the wt LZ (Wz) resulted in reduced Gag cleavage
efficiency (Fig. 2). This may be attributable to the inability of WKz
or KWz to promote Gag-PR multimerization (Fig. 4E).
Although myristylation is required for Gag membrane binding
(which may in turn promote efficient Gag multimerization [32]),
we found evidence that myr- Gag/Pol or MoGag/Pol were
capable of mediating Pr55
gag processing (Figs. 5 and 6). This
finding suggests that neither membrane association nor an
assembly-competent Gag domain is essential for the activation of
PR embedded in Gag-Pol. It is likely that myr- Gag-Pol can still
undergo dimerization to a level that is sufficient to trigger PR
activation. Previous studies have shown that myr- Gag-Pol can
efficiently cleave Pr55
gag in trans and be packaged into Pr55
gag VLPs
[4,7,35]. The multimerization defect as a result of membrane
binding apparently does not significantly compromise the LZ
enhancement of PR-mediated Gag cleavage.
The next question is why premature PR-mediated Gag and
Gag-Pol cleavage do not occur during virus assembly, given that
multiple assembly domains outside of protease promote Gag-Pol
multimerization. One possibility is that the transframe peptide
p6
pol may play a role in modulating PR dimer interface interaction,
thus preventing premature PR activation. Due to a blocking
mutation at the p6
pol/PR cleavage, p6
pol-retaining PR is defective
in mediating virus maturation [42,43,44,45], suggesting that a fully
functional PR requires the removal of p6
pol. However, to our
knowledge there are no reports on the role of p6
pol in PR dimer
interaction in a Gag-Pol context. We found that a Gag-Pol mutant
with deleted p6
pol was incapable of efficiently processing
coexpressed Pr55
gag, which argues against the possibility of p6
pol
playing a role in suppressing PR activation [46]. According to one
recent study, the insertion of a larger reporter sequence in the p6
pol
region markedly impairs virus maturation, whereas partial
substitution with a heterologous sequence does not [47]. This
suggests that structural conformation, rather than a specific
sequence upstream of PR, is important for determining PR
activation.
Although the RT domain is essential for proper PR-mediated
Gag cleavage, the RT homodimerization domain has no
enhancement effect on Gag cleavage [48] unless EFV (an HIV-1
RT-dimerization enhancer) is added to culture medium [23,49].
In contrast, we found that LZ is capable of triggering Gag cleavage
enhancement when placed at the PR C-terminus. The RT domain
apparently plays a role in preventing premature PR activation.
Previous studies suggest that the downstream structural confor-
mation of PR is important in terms of modulating PR activation.
First, a single RT amino acid substitution (W402A) that is not
known to have major impacts on in vitro RT dimerization [50]
markedly enhances Gag processing [31]. An additional partial
deletion at the C-terminus of p66RT not only reverses W402A-
triggered Gag cleavage enhancement, but also markedly impairs
virus maturation. In contrast, truncated Gag-Pol mutants that
retain intact p66 or p51 RT domains still respond to the
enhancement effect of W402A on Gag processing [31]. Second,
substitution mutations in RT are capable of neutralizing the
enhancement effect of EFV on Gag processing [49]. Combined,
these data suggest that conformational changes in Gag-Pol may
significantly affect PR dimer interface interactions, leading to
either premature or insufficient PR activation. Our finding that
the fusion of HIV-1-unrelated dimerization protein sequences at
the C-terminus of PR sharply enhanced Gag cleavage strongly
supports the hypothesis that structural conformation, rather than
specific sequences, largely determines PR activation status. The
RT structure domain in the Gag-Pol context may help prevent PR
from premature activation via a conformation that prevents the
Figure 4. Effects of leucine zipper domain insertion on Gag-PR multimerization and assembly. (A) Schematic representations of HIV-1
Gag and Gag-LZ chimeras. HIV-1 Gag domains, pol-encoded PR, and the transframe peptide p6
pol are indicated; fs denotes a frameshift mutation that
forces gag and pol into the same reading frame. The fused leucine zipper (LZ) domains wt (Wz) or mutant (Kz) at the PR C-terminus are indicated as
described in the Figure 1 legend; x denotes substitution mutations in CA, NC (NC15A), and PR that blocked either Gag assembly or PR activity. (B–E)
Assembly and multimerization of HIV-1 Gag mutants. 293T cells were transfected with designated constructs. At 48–72 h post-transfection, culture
supernatants and cells were collected and subjected to Western immunoblotting (panels B and C). (D) Gag-associated proteins from medium or cell
samples were quantified by scanning immunoblot band densities (C). Ratios of Gag in media to Gag in cells were determined for each construct, and
compared with wt release level by dividing the release ratio for each chimera by the wt ratio. (E) Velocity sedimentation analysis of cytoplasmic Gag
precursor and Gag-LZ chimeras. Homogenized and extracted cytoplasmic lysates were centrifuged through consecutive 25%, 35%, and 45% sucrose
gradients at 130,0006g for 1 hour. Fractions were collected from the top of each gradient. Aliquots of each fraction were subjected to SDS-PAGE
(10%) and probed with a monoclonal antibody directed against HIV-1 CA.
doi:10.1371/journal.pone.0032845.g004
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PLoS ONE | www.plosone.org 8 March 2012 | Volume 7 | Issue 3 | e32845PR dimer interface from interacting efficiently. This conformation
may change during Gag-Pol packaging, thus supporting more
efficient PR dimer interaction.
Pettit et al. [41] have demonstrated that inactivated PR dimer
interface mutations can be compensated for to some extent by
extra PR sequences in the Gag-Pol context. Altered PR
dimerization kinetics or activity has been identified in several
studies of PR-containing C- or N-terminal extensions into Gag-Pol
[21,23,24,38,40,43,51,52]. In most cases, it is not feasible to assay
the impacts of these constructs on virus assembly or PR-mediated
virus maturation, due to overlapping gag and pol reading frames.
Our approach provides a convenient system for analyzing the
impacts of mutations on PR dimer interactions by assessing virus
particle assembly and processing. Studies are underway to
determine if LZ sufficiently compensates for the inactivation of
PR dimer interface mutations.
Materials and Methods
Plasmid construction
To place a leucine zipper (LZ) in frame into the HIV-1 PR C-
terminus, we engineered a pBRCla-Sal plasmid cassette contain-
ing an HIV-1 coding sequence (from ClaI-nt.831 to SalI-nt.5786)
and a pcDNA3.1-myc/hisA polylinker inserted at the IN C-
terminus. DNC(wtZip) and DNC(Kzip) [53] served as templates
for amplifying the respective wt and mutant LZ domains of human
CREB [54] using the forward primer 59-CGGGATCCTGGAG-
GAGGACGAGAGTGTCGTAG-AAAGAAG-39 and reverse
primer 59-CCAAGCGGCCGCGATTTGTGGCAG-TAT-39.
Plasmids containing the wt and mutant LZ (provided by E.
Barklis [55]) were used to construct the DNC(wtZip) and
DNC(Kzip). The human CREB LZ sequence is 284-RE-
CRRKKKEYVKCLENRVAVLENQNKTLIEELKALKDLYC-
HKSD-327. The underlined amino acid residues E298, R300,
E305, Q307, I312, E314, and L321 were mutated to Lys, and
N308 was mutated to His, yielding the mutant LZ [54]. Amplified
fragments were digested with BamHI and NotI and ligated into
the pBRCla-Sal cassette, yielding constructs PRWz and PRKz,
respectively. To add the LZ copy, PCR-amplified wt and mutant
LZ fragments were purified, digested with a restriction enzyme,
and ligated into the PRWz and PRKz, yielding the constructs
PRWWz, PRWKz, PRKKz, and PRKWz.
The Gag assembly-defective mutant MoGag was constructed by
recombining the CA mutant M39A/W184A/M185A with NC
mutant NC15A, which was kindly provided by P. Spearman [56].
NC15A has 15 NC-basic residues replaced with alanine. M39A/
W184A/M185A was created by overlapping PCR with the
following mutagenic primers: for M39A, 59-CTGATAGCGCT-
GAAAATGCGGGTATCA-39, and for W184A/M185A, 59-
CAACAACGTTTCTGTAGCCGCATTTTTTAC-39. The Mo-
Gag mutation was cloned into the indicated PR-leucine zipper
constructs. As described previously, Gag/PR has deleted RT and
IN coding sequences [23]. In D25, Arg is substituted for the PR
catalytic residue Asp [20]. The backbone of all expression
constructs is the HIV-1 proviral plasmid HIVgpt [57].
Cell culture and transfection
293T cells were maintained in DMEM supplemented with 10%
fetal calf serum. Confluent 293T cells were trypsinized, split 1:10
and seeded onto 10-cm dish plates 24 hours before transfection.
For each construct, 293T cells were transfected with 20 mgo f
plasmid DNA by the calcium phosphate precipitation method (18),
with the addition of 50 mM chloroquine to enhance transfection
efficiency.
Western immunoblot analysis
Culture media from transfected 293T cells were filtered through
0.45 mm-pore-size filters, followed by centrifugation through 2 ml
of 20% sucrose in TSE (10 mM Tris-HCl pH 7.5, 100 mM NaCl,
1 mM EDTA) plus 0.1 mM phenylmethylsulfonyl fluoride
[PMSF]) at 4uC for 40 min at 274,0006g (SW41 rotor at
40,000 rpm). Viral pellets then were suspended in IPB (20 mM
Figure 5. Effects of LZ domain insertion on Gag cleavage. (A) Schematic representations of HIV-1 mutants. Indicated are domains for HIV-1
Gag and pol-encoded p6
pol, PR, and RT. Wild-type (Wz) and mutant (Kz) leucine zipper domains and ‘‘x’’ substitution mutations blocking Gag
assembly are indicated as described above. (B–C) 293T cells were transfected with designated constructs. At 4 h post-transfection, equal amounts of
cells were placed on two dish plates. Panel B: Cells were collected 24 and 48 h post-transfection and subjected to Western immunoblotting. Cellular
Pr55
gag and p24
gag levels were quantified by scanning immunoblot band densities. Ratios of p24
gag to p55
gag were determined for each mutant and
normalized to those of wt in parallel experiments. Bars indicate standard deviation. **, p,0.01. Panel C: Supernatants and cells were collected 48–
72 h post-transfection following treatment with or without 5 mM of HIV-1 protease inhibitor Saquinavier. Samples were prepared and subjected to
Western immunoblotting.
doi:10.1371/journal.pone.0032845.g005
Figure 6. The enhancement effect of LZ on Gag cleavage is
independent of myristylation. 293T cells were transfected with
designated constructs containing a normal myristylation or myristyla-
tion-minus (myr-) mutation (lanes 5–8). At 4 h post-transfection, equal
amounts of cells were placed on two dish plates. Cells and culture
supernatants were collected at 24 and 48 h post-transfection and
analyzed by Western immunoblotting.
doi:10.1371/journal.pone.0032845.g006
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sodium deoxycholate, 1% Triton X-100, 0.02% sodium azide)
plus 0.1 mM PMSF. Cells were rinsed with ice-cold PBS
(phosphate-buffered saline), scraped from the plates, collected in
1 ml of PBS and pelleted at 2,500 rpm for 5 min. The cell pellets
were resuspended in 250 ml of IPB plus 0.1 mM PMSF, and then
subjected to microcentrifugation at 4uC for 15 min at 13,7006g
(14,000 r.p.m.) to remove cell debris. Either supernatant or cell
sample was then mixed with equal volumes of 26sample buffer
(12.5 mM Tris-HCl pH 6.8, 2% SDS, 20% glycerol, 0.25%
bromophenol blue) and 5% b-mercaptoethanol and boiled for
5 min. Samples were subjected to SDS-PAGE and electroblotted
onto nitrocellulose membranes. Membrane-bound Gag proteins
were immunodetected using an anti-p24
gag (mouse hybridoma
clone 183-H12-5C) monoclonal antibody at a 1:5,000 dilution
from ascites. The secondary antibody was a rabbit anti-mouse
(HRP)-conjugated antibody at 1:15,000 dilution as appropriate
and the procedures used for HRP activity detection followed the
manufacturer’s protocol (Pierce). Immunodetected bands on film
were quantified by using AlphaImager 2000 (Alpha Innotech
Corp.) and Image J software.
Velocity sedimentation analysis of cytoplasmic Gag
proteins
Cells were rinsed twice with PBS, pelleted and resuspended in
1 ml TEN buffer containing Complete protease inhibitor cocktail
followed by homogenization. The cell lysates then were centri-
fuged at 3,000 rpm for 20 min at 4uC. Five hundred ml of the
postnuclear supernatants were mixed with an equal amount of
TEN buffer, and were then applied to the top of a pre-made 25–
45% discontinuous sucrose gradient. This gradient was prepared
in TEN buffer containing 1 ml of each of 25%, 35%, and 45%
sucrose. The gradient was then centrifuged at 130,0006g for
1 hour at 4uC. Five 0.8-ml fractions were collected from the top of
the centrifuge tubes. The proteins present in aliquots of each
fraction were precipitated with 10% TCA and subjected to
western blot analysis as described in the membrane flotation assay.
Electron microscopy
Virus-containing supernatants were centrifuged through 20%
sucrose cushion. Concentrated viral sample was placed for 2 min
onto a carbon-coated, UV-treated 200 mesh copper grid as
described [58]. Sample-containing grids were rinsed 15 s in water,
drained off water with filter paper, and stained for 1 min in filtered
1.3% uranyl acetate. Staining solution was drained off by applying
filter paper to the edge of the grid. Grids were left to dry before
viewing in a JOEL JEM-2000 EXII transmission electron
microscope. Images were collected at 20,0006and 60,0006.
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